Ayush Ministry Gets Rs 3,712 Crore In Interim Budget

New Delhi: The interim Budget allocation for the Ayush Ministry has been increased to Rs 3,712.49 crore for 2024-25 from Rs 3,000 crore (revised estimates) in 2023-24, recording a rise of 23.74 percent.

The National Medicinal Plants Board has been allocated Rs 14.63 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) allocated Rs 20.80 crore.

The autonomous bodies have been allocated Rs 1,848.40 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 413.54 crore, Central Council for Research in Homeopathy Rs 144 crore, Central Council for Research in Unani Medicine Rs 228.05 crore and the All India Institute of Ayurveda has got Rs 227.20 crore.

The National Medicinal Plants Board undertakes promotional and contractual farming schemes with a view to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H medicines.

At the initiative of the National Medicinal Plants Board, 32 State Medicinal Plants Boards in 27 states and five Union territories have been constituted for providing impetus to cultivation of high priority medicinal plants for domestic consumption as well as export.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for drug testing of all Ayush drugs in India. Further, it sets standards for all Ayush drugs which are published in the form of Pharmacopoeias.

Related Posts

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

GLP-1 injections recalled across the US over sterility concerns

A nationwide recall of compounded tirzepatide injections in the United States has raised fresh concerns about the safety of weight-loss medicines. The recall, initiated by Apothecary Pharma LLC over concerns…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

GLP-1 injections recalled across the US over sterility concerns

GLP-1 injections recalled across the US over sterility concerns

Govt allows third-party agencies to conduct departmental inspections

Govt allows third-party agencies to conduct departmental inspections

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher